Learn more about Australia

Australia

Since 1993, Quintiles Australia and New Zealand have provided fully integrated services for Phase II-IV clinical studies to the pharmaceutical industry. From offices in five major cities in Australia and a large office in Auckland, New Zealand, hundreds of employees give you responsive service to help you drive your pharmaceutical initiatives. Quintiles’ experience includes studies at about 1,000 different investigator sites since 2004.

Benefits of working with Quintiles Australia and New Zealand

• Pragmatic regulatory environment
• Frequently enroll the first patients worldwide for global studies
• Documents only required in English
• An established network: leverage our well-established relationships with leading medical centers and experienced investigators
• All studies are conducted to FDA and ICH-GCP standards
• Cost-effective: lower pass-through costs and major time savings without any sacrifice of quality
• Ethnic sub-populations
• Ample Internet access for immediate availability of data and reports
• Southern hemisphere advantage of reverse seasonality, boosting global recruitment
• Fast, efficient access to large patient and physician populations: more than 24 million concentrated in major cities and approximately 40,000 physicians
• Highest standards: data submitted are accepted by the US FDA and EMEA for pivotal submissions
• A broad range of disease profiles, including diabetes, cardiovascular diseases, cancer, neurological and infectious diseases

Key Services in Australia and New Zealand

• Biostatistics
• Clinical Monitoring and Site Management
• Data Management
• Medical Writing
• Project Management
• Regulatory Services

Access through Our Australia and New Zealand Teams to Quintiles Worldwide

• Central labs
• ECG services
• Drug safety/pharmacovigilance
• Consulting services
• Partnering